pentamidine (Q416206)

DrugBank

17 November 2015

Pentamidine-skeletal.svg
512 × 135; 6 KB

0 references

mass

340.19 dalton

1 reference

pentamidine (English)

17 November 2016

chemical formula

C₁₉H₂₄N₄O₂

1 reference

pentamidine (English)

17 November 2016

canonical SMILES

C1=CC(=CC=C1C(=N)N)OCCCCCOC2=CC=C(C=C2)C(=N)N

1 reference

World Health Organisation international non-proprietary name

pentamidine (English)

17 November 2016

1 reference

14 February 2018

pentamidine (English)

1 reference

pentamidine (English)

medical condition treated

19 October 2016

parasitic protozoa infectious disease

1 reference

13 December 2016

visceral leishmaniasis

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

terfenadine

1 reference

High-priority drug–drug interactions for use in electronic health records

procainamide

1 reference

High-priority drug–drug interactions for use in electronic health records

chloroquine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

anagrelide

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

astemizole

1 reference

High-priority drug–drug interactions for use in electronic health records

azithromycin

1 reference

High-priority drug–drug interactions for use in electronic health records

bepridil

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

cisapride

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-citalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

cocaine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

dofetilide

1 reference

High-priority drug–drug interactions for use in electronic health records

domperidone

1 reference

High-priority drug–drug interactions for use in electronic health records

dronedarone

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

escitalopram

1 reference

High-priority drug–drug interactions for use in electronic health records

flecainide

1 reference

High-priority drug–drug interactions for use in electronic health records

halofantrine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

ibutilide

1 reference

High-priority drug–drug interactions for use in electronic health records

mesoridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-methadone

1 reference

High-priority drug–drug interactions for use in electronic health records

moxifloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

ondansetron

1 reference

High-priority drug–drug interactions for use in electronic health records

pimozide

1 reference

High-priority drug–drug interactions for use in electronic health records

probucol

1 reference

High-priority drug–drug interactions for use in electronic health records

quinidine

1 reference

High-priority drug–drug interactions for use in electronic health records

sevoflurane

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

High-priority drug–drug interactions for use in electronic health records

sparfloxacin

1 reference

High-priority drug–drug interactions for use in electronic health records

(RS)-sulpiride

1 reference

High-priority drug–drug interactions for use in electronic health records

thioridazine

1 reference

High-priority drug–drug interactions for use in electronic health records

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ondansetron

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

zuclopenthixol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Pasireotide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

foscarnet

nephrotoxicity

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

foscarnet

hypocalcaemia

1 reference

probably

A reference set of clinically relevant adverse drug-drug interactions

nephrotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

nephrotoxicity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tacrolimus

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pregnancy category

US pregnancy category C

1 reference

imported from Wikimedia project

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

1 reference

Medical Subject Headings

15 March 2018

0 references

1 reference

Pentamidine

0 references

Identifiers

InChI

InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)

1 reference

pentamidine (English)

XDRYMKDFEDOLFX-UHFFFAOYSA-N

17 November 2016

InChIKey

2 references

pentamidine (English)

17 November 2016

ChEBI release 2020-09-01

CAS Registry Number

100-33-4

2 references

pentamidine (English)

XDRYMKDFEDOLFX-UHFFFAOYSA-N

17 November 2016

InChIKey

8 April 2021

https://commonchemistry.cas.org/detail?cas_rn=100-33-4

1 reference

pentamidine (English)

17 November 2016

1 reference

pentamidine (English)

17 November 2016

Reaxys registry number

3159790

1 reference

pentamidine (English)

19 October 2016

ChEBI ID

45081

mapping relation type

1 reference

PENTAMIDINE (English)

17 November 2016

1 reference

splash10-0006-0009000000-18ffa88d8e83e0c224b3

PENTAMIDINE (English)

17 November 2016

1 reference

MassBank accession ID

MSBNK-Fiocruz-FIO00450

0 references

MSBNK-Fiocruz-FIO00451

0 references

MSBNK-Fiocruz-FIO00452

0 references

MSBNK-Fiocruz-FIO00453

0 references

MSBNK-Fiocruz-FIO00454

0 references

MSBNK-Keio_Univ-KO003937

0 references

MSBNK-Keio_Univ-KO003938

0 references

MSBNK-Keio_Univ-KO003939

0 references

MSBNK-Keio_Univ-KO003940

0 references

MSBNK-Keio_Univ-KO003941

0 references

MSBNK-Keio_Univ-KO009179

0 references

MSBNK-Keio_Univ-KO009180

0 references

MSBNK-Keio_Univ-KO009181

0 references

SPLASH

0 references

splash10-00di-0309000000-22a206e2fffa6ce5cf2f

0 references

splash10-00dr-0900000000-d135e9c44dbf5da10735

0 references

splash10-00di-0900000000-d01e29cdf614c3660180

0 references

splash10-0006-0009000000-1499530d0d768e480fd7

0 references

splash10-0006-0009000000-3c60569ced478a95001f

0 references

splash10-00di-0209000000-58a168dde59140860009

0 references

splash10-00dr-0901000000-7cd36861b140e4e5a6a2

0 references

splash10-00di-0900000000-60dfcd75868e869bcbf7

0 references

splash10-00di-0009000000-6677c6c06aa266d05ff1

0 references

splash10-00dr-0903000000-140ddf0bc9583ef7ea2b

0 references

splash10-00kr-6900000000-e0a164c7a34de0798880

0 references

HSDB ID

7474

1 reference

Hazardous Substances Data Bank

28 October 2019

PENTAMIDINE (English)

10 May 2021

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

202-841-0

1 reference

pentamidine (English)

ECHA Substance Infocard ID

17 November 2016

100.002.583

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.002.583

27 December 2018

Pentamidine (English)

quotation

CAS no.: 100-33-4 (English)

MeSH descriptor ID

D010419

subject named as

Pentamidine

0 references

0 references

0 references

1 reference

pentamidine (English)

17 November 2016

1 reference

Pentamidine (English)

Human Metabolome Database ID

17 November 2016

HMDB0014876

1 reference

based on heuristic

inferred from InChIKey

1 reference

pentamidine (English)

MedlinePlus drug identifier

17 November 2016

a685029

route of administration

intramuscular injection

intravenous injection

0 references

a601208

route of administration

inhalation administration

0 references

NDF-RT ID

N0000147966

1 reference

pentamidine (English)

17 November 2016

0 references

1 reference

1 reference

pentamidine (English)

electronic Essential Medicines List medicine ID

19 October 2016

PDB ligand ID

PNT

0 references

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

1 reference

26 January 2022

https://docs.openalex.org/download-snapshot/snapshot-data-format

1 reference

3GY3 (English)

19 October 2016

1 reference

1D64 (English)

19 October 2016

1 reference

3HII (English)

19 October 2016

1 reference

3CR4 (English)

19 October 2016

1 reference

3CR5 (English)

19 October 2016

1 reference

1RKW (English)

19 October 2016

1 reference

3EY0 (English)

19 October 2016

1 reference

pentamidine (English)